STAT3 and neoplasm: Given that HLJ1 may act as a tumor suppressor by dampening tumor growth through STAT3 activation inhibition, further research is essential to elucidate the complex crosstalk between peritumoral HLJ1/STAT3 signaling and liver tumors.